AccuStem Sciences
Business Services · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
5 Penn Plz Fl 19, New York City, New Yor...Website
www.accustem.comRevenue
-Stock Symbol
ACUTIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About AccuStem Sciences
AccuStem is an early-stage life sciences company focused on developing and commercializing innovative products for the treatment and management of all cancers. The company aims to enhance cancer detection and improve patient outcomes by creating advanced diagnostic tools for patients, physicians, and care teams. AccuStem is committed to providing a comprehensive suite of diagnostics that support decision-making throughout the oncology care continuum. Their current projects include novel genomic tests designed for cancer screening and treatment planning.Explore more
AccuStem Sciences Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AccuStem Sciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once AccuStem Sciences has new funding data
Product Launch: Get notified when AccuStem Sciences launches new products
Check out if AccuStem Sciences is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at AccuStem Sciences
Earning: See what the market has to say on AccuStem Sciences recently announced quarterly report
Website visits: Recent activity has been detected on your website
AccuStem Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Check if AccuStem Sciences has recently received funding, and reach out quickly before it becomes old news!
Click to see if AccuStem Sciences had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to AccuStem Sciences
Compare insights from companies similar to AccuStem Sciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
AccuStem Sciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
AccuStem Sciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about AccuStem Sciences.
AccuStem Sciences Tech Stack
A closer look at the technologies used by AccuStem Sciences
Most Recent Scoops
Left Company
Executive Move
Left Company
Executive Move
Executive Move
Board of Directors
Initial Public Offering (IPO)
AccuStem Sciences News & Media
AccuStem Sciences and EmeritusDX Expand Blood-Based Testing Capabilities to Advance Cancer Diagnostics and Treatment Planning
PHOENIX, Ariz. and LONDON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, today announced an expansion of its blood-based testing capabilities in partnership with EmeritusDX, a rapidly growing cancer diagnostics and information company. The two companies are building out their best-in-class product portfolios and respective infrastructures to meet growing clinicAccuStem Sciences to Present at the Life Sciences Virtual Investor Forum September 18th
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.comAccuStem Sciences, Inc. Announces Chairman Purchase of Shares
LONDON, June 13, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced that its Chairman of the Board, Mr. Gabriele Cerrone, has notified the Company that he has recently purchased an additional 8,991 ACUT shares in the open market. This brings his total holding to 6,500,000 shares.AccuStem Sciences, Inc. and EmeritusDX Announce Partnership to Commercialize MSC Test for Lung Cancer Screening
LONDON and PHOENIX, Ariz., April 28, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, and EmeritusDX, a rapidly growing cancer diagnostics and information company, are pleased to announce the expansion of their strategic partnership to include the commercialization of the MSC test for lung cancer screening. This collaboration aims to enhance the accuracy of lung nodule stra
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AccuStem Sciences
Sign Up For FreeTo access detailed company insights
AccuStem is an early-stage life sciences company focused on developing and commercializing innovative products for the treatment and management of all cancers. The company aims to enhance cancer detection and improve patient outcomes by creating advanced diagnostic tools for patients, physicians, and care teams. AccuStem is committed to providing a... Read More
